Cargando…

Dysregulation of exosomal miR-192 and miR-194 expression in lung adenocarcinoma patients

Non-small cell lung cancer (NSCLC) is the main reason of cancer linked mortality and around 80% of cases diagnosed in advanced stage. Therefore current study designed to evaluate the deregulation of miRNA-194 and miRNA-192 in different body fluid of Non small cell lung cancer participants. Present s...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tongfei, Li, Wei, Li, Haitao, Li, Weina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938118/
https://www.ncbi.nlm.nih.gov/pubmed/33732041
http://dx.doi.org/10.1016/j.sjbs.2021.01.013
_version_ 1783661537370570752
author Wang, Tongfei
Li, Wei
Li, Haitao
Li, Weina
author_facet Wang, Tongfei
Li, Wei
Li, Haitao
Li, Weina
author_sort Wang, Tongfei
collection PubMed
description Non-small cell lung cancer (NSCLC) is the main reason of cancer linked mortality and around 80% of cases diagnosed in advanced stage. Therefore current study designed to evaluate the deregulation of miRNA-194 and miRNA-192 in different body fluid of Non small cell lung cancer participants. Present study recruited newly diagnosed histopathologically confirmed. It was observed that the 40% NSCLC participants showed elevated miR-194 expression and 60% NSCLC participants showed reduced miR-194 expression in serum sample while in Bronchial wash, only 20% NSCLC participants showed elevated miR-194 expression while 80% showed reduced miR-194 expression (p = 0.003). It was found that the 54% NSCLC participants showed elevated miR-192 expression and 55% NSCLC participants showed reduced miR-192 expression in serum sample while In Bronchial wash sample, only 25% NSCLC participants showed high miR-192 expression while 75% showed low miR-192 expression (P = 0.0004). Expression of miR-194 was significantly associated with TNM stages (p < 0.0001, p < 0.0001), distant organ metastases (p < 0.0001, p < 0.0001), pathological grade (p = 0.0009, p = 0.0005) among serum sample and bronchial wash sample. Same observation was found with expression of miR-192 and it was significantly associated with TNM stages (p < 0.0001, p < 0.0001), distant organ metastases (p < 0.0001, p < 0.0001), pathological grade (p = 0.006, p = 0.001) among serum sample and bronchial wash sample. It was observed that the NSCLC participants who had high serum based miR-194 expression showed 22 months of overall median survival while low expression of serum based miR-194 expression showed 18 months of overall median survival. Present study suggests that decreased expression of miR-194 and miR-192 was significantly associated with different clinical features of NSCLC cases. However, significantly higher number of NSCLC cases showed low expression of miR-194 and miR-192 in bronchial lavage sample. Decreased poor overall survival was found to be associated with bronchial wash sample with respect to low miR-194 and miR-192 expression while NSCLC participants showed better overall survival with high miR-194 and miR-192 expression. This suggested decreased expression of miR-192 and miR-194 expression could be the potential prognostic marker among NSCLC participants.
format Online
Article
Text
id pubmed-7938118
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-79381182021-03-16 Dysregulation of exosomal miR-192 and miR-194 expression in lung adenocarcinoma patients Wang, Tongfei Li, Wei Li, Haitao Li, Weina Saudi J Biol Sci Original Article Non-small cell lung cancer (NSCLC) is the main reason of cancer linked mortality and around 80% of cases diagnosed in advanced stage. Therefore current study designed to evaluate the deregulation of miRNA-194 and miRNA-192 in different body fluid of Non small cell lung cancer participants. Present study recruited newly diagnosed histopathologically confirmed. It was observed that the 40% NSCLC participants showed elevated miR-194 expression and 60% NSCLC participants showed reduced miR-194 expression in serum sample while in Bronchial wash, only 20% NSCLC participants showed elevated miR-194 expression while 80% showed reduced miR-194 expression (p = 0.003). It was found that the 54% NSCLC participants showed elevated miR-192 expression and 55% NSCLC participants showed reduced miR-192 expression in serum sample while In Bronchial wash sample, only 25% NSCLC participants showed high miR-192 expression while 75% showed low miR-192 expression (P = 0.0004). Expression of miR-194 was significantly associated with TNM stages (p < 0.0001, p < 0.0001), distant organ metastases (p < 0.0001, p < 0.0001), pathological grade (p = 0.0009, p = 0.0005) among serum sample and bronchial wash sample. Same observation was found with expression of miR-192 and it was significantly associated with TNM stages (p < 0.0001, p < 0.0001), distant organ metastases (p < 0.0001, p < 0.0001), pathological grade (p = 0.006, p = 0.001) among serum sample and bronchial wash sample. It was observed that the NSCLC participants who had high serum based miR-194 expression showed 22 months of overall median survival while low expression of serum based miR-194 expression showed 18 months of overall median survival. Present study suggests that decreased expression of miR-194 and miR-192 was significantly associated with different clinical features of NSCLC cases. However, significantly higher number of NSCLC cases showed low expression of miR-194 and miR-192 in bronchial lavage sample. Decreased poor overall survival was found to be associated with bronchial wash sample with respect to low miR-194 and miR-192 expression while NSCLC participants showed better overall survival with high miR-194 and miR-192 expression. This suggested decreased expression of miR-192 and miR-194 expression could be the potential prognostic marker among NSCLC participants. Elsevier 2021-03 2021-01-20 /pmc/articles/PMC7938118/ /pubmed/33732041 http://dx.doi.org/10.1016/j.sjbs.2021.01.013 Text en © 2021 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Wang, Tongfei
Li, Wei
Li, Haitao
Li, Weina
Dysregulation of exosomal miR-192 and miR-194 expression in lung adenocarcinoma patients
title Dysregulation of exosomal miR-192 and miR-194 expression in lung adenocarcinoma patients
title_full Dysregulation of exosomal miR-192 and miR-194 expression in lung adenocarcinoma patients
title_fullStr Dysregulation of exosomal miR-192 and miR-194 expression in lung adenocarcinoma patients
title_full_unstemmed Dysregulation of exosomal miR-192 and miR-194 expression in lung adenocarcinoma patients
title_short Dysregulation of exosomal miR-192 and miR-194 expression in lung adenocarcinoma patients
title_sort dysregulation of exosomal mir-192 and mir-194 expression in lung adenocarcinoma patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938118/
https://www.ncbi.nlm.nih.gov/pubmed/33732041
http://dx.doi.org/10.1016/j.sjbs.2021.01.013
work_keys_str_mv AT wangtongfei dysregulationofexosomalmir192andmir194expressioninlungadenocarcinomapatients
AT liwei dysregulationofexosomalmir192andmir194expressioninlungadenocarcinomapatients
AT lihaitao dysregulationofexosomalmir192andmir194expressioninlungadenocarcinomapatients
AT liweina dysregulationofexosomalmir192andmir194expressioninlungadenocarcinomapatients